Reichert, C.; Baldini, C.; Mezghani, S.; Maubec, E.; Longvert, C.; Mortier, L.; Quereux, G.; Jannic, A.; Machet, L.; de Quatrebarbes, J.;
et al. Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients. Cancers 2023, 15, 4330.
https://doi.org/10.3390/cancers15174330
AMA Style
Reichert C, Baldini C, Mezghani S, Maubec E, Longvert C, Mortier L, Quereux G, Jannic A, Machet L, de Quatrebarbes J,
et al. Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients. Cancers. 2023; 15(17):4330.
https://doi.org/10.3390/cancers15174330
Chicago/Turabian Style
Reichert, Constance, Capucine Baldini, Sarah Mezghani, Eve Maubec, Christine Longvert, Laurent Mortier, Gaëlle Quereux, Arnaud Jannic, Laurent Machet, Julie de Quatrebarbes,
and et al. 2023. "Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients" Cancers 15, no. 17: 4330.
https://doi.org/10.3390/cancers15174330
APA Style
Reichert, C., Baldini, C., Mezghani, S., Maubec, E., Longvert, C., Mortier, L., Quereux, G., Jannic, A., Machet, L., de Quatrebarbes, J., Nardin, C., Beneton, N., Amini Adle, M., Funck-Brentano, E., Descamps, V., Hachon, L., Malissen, N., Baroudjian, B., & Brunet-Possenti, F., on behalf of the Groupe de Cancérologie Cutanée.
(2023). Combined Nivolumab and Ipilimumab in Octogenarian and Nonagenarian Melanoma Patients. Cancers, 15(17), 4330.
https://doi.org/10.3390/cancers15174330
